Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib, Valproic Acid, and Sildenafil in Recurrent High-Grade Glioma
NCT01817751Phase 2Completed
- Sponsor
- Virginia Commonwealth University
- Start
- Apr 2013
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib, valproic acid, ASP-001 in glioma, sponsored by Virginia Commonwealth University. Started Apr 2013; status: completed.
02
Drugs
sorafenibvalproic acidASP-001
03
Conditions
glioma
Beyond the preview
Go deeper on NCT01817751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01817751.